Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2026-525935-18-01Phase 2Authorised
Phase 2, randomised trial comparing Testosterone undecanoate with Placebo (2 arms). Primary endpoints: Recovery of countermovement jump height, Recovery of lower-body explosive performance and 3 more. Planned start Oct 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2026-525935-18-01.